Neoadjuvant Immune Checkpoint Blockade: A Window into Treatment Response and Pri
PharmaTalkRadio13 Jan 2023

Neoadjuvant Immune Checkpoint Blockade: A Window into Treatment Response and Pri

Neoadjuvant (pre-surgical) immune checkpoint blockade may prevent cancer relapse and progression.This treatment approach is now FDA-approved for resectable triple-negative breast cancer, and hundreds of clinical trials in other cancers are ongoing.Surgical resection specimens collected after several weeks of neoadjuvant ICB offer vast opportunities for predictive biomarker discovery and understanding ICB response/resistance. Suzanne Topalian, MD, Associate Director / Professor of Surgery, Bloomberg~Kimmel Institute for Cancer Immunotherapy / Johns Hopkins University Learn more about the IO360° Summit at www.io360summit.com

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(461)

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
kapitalet-en-podd-om-ekonomi
angestpodden
rss-ai-med-jonas-benjamin
rss-ronden
rss-mottagningen
halsorevolutionen
medicinvetarna
det-morka-psyket
sexet
rss-vetenskapsradion-2
bildningspodden
rss-experimentet
rss-ufobortom-rimligt-tvivel
bildningskomplexet
rss-spraket
ufo-sverige
rss-vetenskapsradion